Mesenchymal stem cells and immunomodulation: current status and future prospects.

Area of Science:

• Immunology
• Stem Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess unique immunomodulatory properties beneficial for tissue repair in chronic inflammation and autoimmune diseases.
• MSCs show potential in treating immune disorders like graft versus host disease (GvHD) and allergic conditions.
• Widespread clinical application of MSCs faces significant challenges that require further investigation.

Purpose of the Study:

• To review preclinical and clinical studies on MSCs from various adult tissues.
• To discuss current obstacles hindering the clinical use of MSCs.
• To propose pluripotent stem cell-derived MSCs as a future strategy for immunomodulation therapy.

Main Methods:

• Literature review of preclinical and clinical studies involving MSCs.
• Analysis of MSC biological properties and immunomodulatory mechanisms.
• Discussion of challenges and future directions in MSC-based therapies.

Main Results:

• MSCs demonstrate significant potential in preclinical and clinical settings for immune disorder treatment.
• Key challenges identified include standardization, efficacy, and safety concerns for widespread clinical application.
• Pluripotent stem cell-derived MSCs are proposed as a promising avenue for overcoming current limitations.

Conclusions:

• Understanding MSC biology is crucial for advancing MSC-based transplantation for immunomodulation.
• Addressing current hurdles is essential for the successful clinical translation of MSC therapies.
• Future development of pluripotent stem cell-derived MSCs offers a novel approach to immunomodulation therapy.